Literature DB >> 3276975

Immunoglobulin G and its function in the human respiratory tract.

H Y Reynolds1.   

Abstract

Immunoglobulin G--which can be subdivided into four classes, each with different functional characteristics--is an important component of the host defense system of the respiratory tract. An excessive amount can be produced or can accumulate after airway irritation (exposure to cigarette smoke) or from immunologic stimulus of B-lymphocyte-plasma cells in types of hypersensitivity and interstitial lung diseases. Specific antibody activity can be identified in organic dust-induced hypersensitivity pneumonitis and asthma that contributes to disease pathogenesis. The availability of opsonic antimicrobial antibodies is essential for optimal function of phagocytes in uptake and containment of bacteria. With an absolute or functional deficiency of IgG, recurrent and chronic types of sinopulmonary infections occur. These extremes of IgG availability, either high levels (presumably excessive) or deficient, are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276975     DOI: 10.1016/s0025-6196(12)64949-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

Review 1.  The effects of acute and chronic exercise of immunoglobulins.

Authors:  D C Nieman; S L Nehlsen-Cannarella
Journal:  Sports Med       Date:  1991-03       Impact factor: 11.136

2.  Independence of neutrophil respiratory burst oxidant generation from the early cytosolic calcium response after stimulation with unopsonized Candida albicans hyphae.

Authors:  D R Wysong; C A Lyman; R D Diamond
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 3.  Hidden risks for pneumonia in Malawi.

Authors:  D G Fullerton; S B Gordon
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

Review 4.  The pathogenesis of ventilator-associated pneumonia: II. The lower respiratory tract.

Authors:  G U Meduri; R J Estes
Journal:  Intensive Care Med       Date:  1995-05       Impact factor: 17.440

5.  The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine.

Authors:  Clare M Williams; Sreeja Roy; Danielle Califano; Andrew N J McKenzie; Dennis W Metzger; Yoichi Furuya
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

6.  Differential release of superoxide anions by macrophages treated with long and short fibre amosite asbestos is a consequence of differential affinity for opsonin.

Authors:  I M Hill; P H Beswick; K Donaldson
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

7.  BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections.

Authors:  H Schultz; S Schinke; J Weiss; V Cerundolo; W L Gross; S Gadola
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 8.  SARS-CoV-2 vaccines in development.

Authors:  Florian Krammer
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

9.  Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China.

Authors:  Yonghua Li; Wenning Xu; Zujun Jiang; Yang Gao; Yan Pang; Li Li; Ling OuYang; Leqing Zhang; Zenghui Liu; Yang Wang; Yang Xiao; Xiaojun Huang
Journal:  Tumour Biol       Date:  2014-03-25

Review 10.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.